88 PEAK-1 (NCT07011719): A Randomized, Double-Blind, Active-Control Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma
Toni K Choueiri, Sumanta Pal, Rana R McKay, Cristina Suárez et autres
0 citationsThe Oncologist